openPR Logo
Press release

Allogeneic Hematopoietic Stem Cell Transplant Market is expected to reach nearly USD 7.1 billion by 2034

12-11-2025 01:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Allogeneic Hematopoietic Stem Cell Transplant Market

Allogeneic Hematopoietic Stem Cell Transplant Market

Allogeneic Hematopoietic Stem Cell Transplant Market Overview

The Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Market continues to grow due to rising incidences of hematological malignancies, advancements in donor-matching technologies, and wider availability of transplant centers worldwide. The market is valued at around USD 4.2 billion in 2024 and is expected to reach nearly USD 7.1 billion by 2034, expanding at a CAGR of about 5.3%. Increasing success rates, reduced transplant-related complications, and innovations in conditioning regimens are shaping overall market expansion.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70910

Key Market Drivers
• Rising prevalence of leukemia, lymphoma, myelodysplastic syndromes, and other genetic blood disorders.
• Advancements in HLA typing, unrelated donor registries, and haploidentical transplant techniques.
• Increasing adoption of reduced-intensity conditioning (RIC) and minimally toxic transplant protocols.
• Growth in global bone marrow donor registries and international donor-matching collaborations.
• Better post-transplant care infrastructure and improvements in graft-versus-host disease (GvHD) management.

Challenges
• High treatment and hospitalization costs.
• Risk of acute and chronic GvHD, infections, and organ toxicity.
• Limited availability of fully matched donors in certain regions.
• Lengthy recovery periods and the need for advanced, multidisciplinary care facilities.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/70910/allogeneic-hematopoietic-stem-cell-transplant-market

Market Segmentation
By Transplant Type
• Matched related donor (MRD)
• Matched unrelated donor (MUD)
• Haploidentical donor
• Umbilical cord blood transplant
• Others

By Application
• Leukemia
• Lymphoma
• Myelodysplastic syndromes
• Severe combined immunodeficiencies
• Hemoglobinopathies (e.g., thalassemia, sickle cell disease)
• Bone marrow failure disorders
• Others

By Age Group
• Pediatric
• Adult
• Geriatric

By End User
• Hospitals
• Transplant centers
• Research institutes
• Academic medical centers

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70910

Regional Insights
• North America leads the market with large donor databases, advanced transplant centers, and strong insurance support.
• Europe holds significant share owing to established transplant programs, high clinical research involvement, and well-coordinated donor networks.
• Asia-Pacific is the fastest-growing region due to rising leukemia cases, expanding healthcare infrastructure, and increased government funding.
• Latin America and Middle East & Africa are gradually improving in transplant capabilities, supported by international collaborations and donor-hub expansions.

Key Companies
Novartis, Pfizer, Sanofi, Gilead Sciences, Mallinckrodt Pharmaceuticals, MediGene AG, Lonza Group, Bluebird Bio, Merck & Co., and Takeda Pharmaceuticals.

Future Outlook
Market growth is expected to accelerate due to gene-editing integration, expansion of haploidentical transplants, and breakthroughs in GvHD prophylaxis. Rising global donor participation, improved survival outcomes, and next-generation conditioning therapies will further transform the HSCT landscape through 2034.

This report is also available in the following languages : Japanese (同種造血幹細胞移植市場), Korean (동종 조혈 줄기세포 이식 시장), Chinese (异基因造血干细胞移植市场), French (Marché de la greffe de cellules souches hématopoïétiques allogéniques), German (Markt für allogene hämatopoetische Stammzelltransplantation), and Italian (Mercato del trapianto allogenico di cellule staminali emopoietiche), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70910

Our More Reports:

Endometriosis Patient Pool Market
https://exactitudeconsultancy.com/reports/70745/endometriosis-patient-pool-market

Chronic Rhinosinusitis without Nasal Polyps Market
https://exactitudeconsultancy.com/reports/70758/chronic-rhinosinusitis-without-nasal-polyps-market

Nasal Polyposis Market
https://exactitudeconsultancy.com/reports/70749/nasal-polyposis-market

Chronic Otitis Media Market
https://exactitudeconsultancy.com/reports/70751/chronic-otitis-media-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allogeneic Hematopoietic Stem Cell Transplant Market is expected to reach nearly USD 7.1 billion by 2034 here

News-ID: 4311833 • Views:

More Releases from Exactitude Consultancy

Acute Gout Flare Market Trends, Drivers, and Competitive Landscape
Acute Gout Flare Market Trends, Drivers, and Competitive Landscape
The Acute Gout Flare Market focuses on treatments that address sudden and severe episodes of gout-related joint pain, inflammation, and swelling. It includes NSAIDs, corticosteroids, colchicine formulations, biologics, and emerging targeted therapies that aim to rapidly reduce uric acid-induced inflammatory responses. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70980 Key Players • Novartis • Takeda • Horizon Therapeutics • Teijin Pharma • Grunenthal • Cipla • Sun Pharma • Mylan • Dr. Reddy's Laboratories • AbbVie Explore Full Report here: https://exactitudeconsultancy.com/reports/70980/acute-gout-flare-market Key Events in the Market • Development of targeted IL-1 inhibitors for acute
Bone Metastasis Market projected to reach approximately USD 29.8 billion by 2034
Bone Metastasis Market projected to reach approximately USD 29.8 billion by 2034
Bone Metastasis Market Overview The Bone Metastasis Market is growing steadily due to the rising global cancer burden, increased early detection rates, and expanding availability of targeted and supportive therapies. The market is estimated at around USD 17.4 billion in 2024 and is projected to reach approximately USD 29.8 billion by 2034, registering a CAGR of about 5.5% during the forecast period. Advances in oncology drugs, palliative care solutions, and
Chronic Pain Market is projected to grow to around USD 90 billion by 2034
Chronic Pain Market is projected to grow to around USD 90 billion by 2034
The global Chronic Pain Market was valued at approximately USD 60 billion in 2024 and is projected to grow to around USD 90 billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of about 5.5 % between 2025 and 2034. Growth is underpinned by rising prevalence of chronic pain conditions due to aging populations, increased awareness and diagnosis, and ongoing innovation across pharmacologic, device-based, and digital therapies. Download
Biliary Tumor Market is projected to reach approximately USD 2.8 billion by 2034, reflecting a CAGR of about 7.2%
Biliary Tumor Market is projected to reach approximately USD 2.8 billion by 2034 …
Biliary Tumor Market The Biliary Tumor Market is growing steadily due to rising incidence of bile duct malignancies, increasing demand for advanced diagnostics, and expanding adoption of targeted therapies. The market is estimated at around USD 1.4 billion in 2024 and is projected to reach approximately USD 2.8 billion by 2034, reflecting a CAGR of about 7.2%. Advancements in tumor biology research, improved imaging technologies, and growing awareness of hepatobiliary cancers

All 5 Releases


More Releases for Transplant

Hair Transplant Turkey: A Global Leader in Hair Transplant Excellence
Image: https://www.globalnewslines.com/uploads/2025/05/daf26471928f1f7c9236a0aa89f52fe0.jpg Established in 2013 in Istanbul, Hair of Istanbul [https://www.hairofistanbul.com/] is a globally recognized medical clinic specializing in advanced hair restoration procedures. Over the past decade, the clinic has helped thousands of patients regain their confidence through personalized treatments, becoming one of the most trusted names in the hair transplant industry worldwide. With more than 19,000 successful operations and services offered in 6 different languages, Hair of Istanbul delivers the highest
Hair Transplant in Rajkot - Best Hair Transplant Specialist in Rajkot for Men & …
Hair Transplant in Rajkot - Best Hair Transplant Specialist in Rajkot for Men & Women Hey...! Do you know Which is the important part to look attractive? Hair is the most important part to look attractive and best. Everybody wants to look better in routine life and every occasion. So, it needs to protein and vitamins to maintain your hair strength and hair growth but now everyone has problem from hair
Transplant Diagnostics Market - Pioneering precision in transplant medicine: Adv …
Newark, New Castle, USA: The "Transplant Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Transplant Diagnostics Market: https://www.growthplusreports.com/report/transplant-diagnostics-market/7982 This latest report researches the industry structure, sales, revenue,
Organ Transplant Market | Organogenesis Incorporated, Terumo Co., OrganOX, Trans …
Organ Transplant Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the world Organ Transplant Market. Organ Transplant Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the